Literature DB >> 18033685

Colorectal cancer screening: a comparison of 35 initiatives in 17 countries.

Victoria S Benson1, Julietta Patnick, Anna K Davies, Marion R Nadel, Robert A Smith, Wendy S Atkin.   

Abstract

Although in its infancy, organized screening for colorectal cancer (CRC) in the general population is increasing at regional and national levels. Documenting and describing these initiatives is critical to identifying, sharing and promoting best practice in the delivery of CRC screening. Subsequently, the International Colorectal Cancer Screening Network (ICRCSN) was established in 2003 to promote best practice in the delivery of organized screening programs. The initial aim was to identify and document organized screening initiatives that commenced before May 2004. Each identified initiative was sent 1 questionnaire per screening modality: fecal occult blood test, flexible sigmoidoscopy or total colonoscopy. Information was collected on screening methodology, testing details and initiative status. In total, 35 organized initiatives were identified in 17 countries, including 10 routine population-based screening programs, 9 pilots and 16 research projects. Fecal occult blood tests were the most frequently used screening modality, and total colonoscopy was seldom used as a primary screening test. The eligible age for screening ranged from 40 years old to no upper limit; most initiatives included participants aged 50 to 64. Recruitment was usually done by a mailed invitation or during a visit to a family physician. In conclusion, this is the first investigation describing the delivery of CRC screening protocols to various populations. The work of the ICRCSN is enabling valuable information to be shared and a common nomenclature to be established. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18033685     DOI: 10.1002/ijc.23273

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  84 in total

1.  Cancer fatalism and poor self-rated health mediate the association between socioeconomic status and uptake of colorectal cancer screening in England.

Authors:  Anne Miles; Sandra Rainbow; Christian von Wagner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-27       Impact factor: 4.254

2.  How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysis.

Authors:  Ulrike Haug; Amy B Knudsen; Karen M Kuntz
Journal:  Int J Cancer       Date:  2012-03-29       Impact factor: 7.396

Review 3.  [International status colorectal cancer screening and quality assurance of screening-colonoscopy].

Authors:  Nikolaus Patera; Claudia Wild
Journal:  Wien Med Wochenschr       Date:  2013-09-05

Review 4.  FIT testing: an overview.

Authors:  Lukejohn W Day; Taft Bhuket; James Allison
Journal:  Curr Gastroenterol Rep       Date:  2013-11

5.  User's perspectives of barriers and facilitators to implementing quality colonoscopy services in Canada: a study protocol.

Authors:  Gilles Jobin; Marie Pierre Gagnon; Bernard Candas; Catherine Dubé; Anis Ben Abdeljelil; Sonya Grenier
Journal:  Implement Sci       Date:  2010-11-02       Impact factor: 7.327

6.  Concerns and challenges in flexible sigmoidoscopy screening.

Authors:  Akeem O Adebogun; Christine D Berg; Adeyinka O Laiyemo
Journal:  Colorectal Cancer       Date:  2012-08

7.  Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems.

Authors:  Andrea N Burnett-Hartman; Shivan J Mehta; Yingye Zheng; Nirupa R Ghai; Dale F McLerran; Jessica Chubak; Virginia P Quinn; Celette Sugg Skinner; Douglas A Corley; John M Inadomi; Chyke A Doubeni
Journal:  Am J Prev Med       Date:  2016-04-01       Impact factor: 5.043

8.  Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.

Authors:  Iris Lansdorp-Vogelaar; S Lucas Goede; Linda J W Bosch; Veerle Melotte; Beatriz Carvalho; Manon van Engeland; Gerrit A Meijer; Harry J de Koning; Marjolein van Ballegooijen
Journal:  Clin Gastroenterol Hepatol       Date:  2017-07-18       Impact factor: 11.382

9.  Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands.

Authors:  Maaike J Denters; Marije Deutekom; Paul Fockens; Patrick M M Bossuyt; Evelien Dekker
Journal:  BMC Gastroenterol       Date:  2009-04-24       Impact factor: 3.067

10.  The diagnosis of colorectal cancer in patients with symptoms: finding a needle in a haystack.

Authors:  Robert H Fletcher
Journal:  BMC Med       Date:  2009-04-17       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.